Skip to content
healthcare.dev

Ultramicrosize Griseofulvin

NDC 62135-494, Griseofulvin, tablet, from Chartwell RX, LLC..

Product NDC
62135-494
Status
Listed
Labeler
Chartwell RX, LLC.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA061996
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62135-494 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GRISEOFULVIN125 mg/1

Pharmacologic classes

Decreased Mitosis [PE]; Microtubule Inhibition [PE]; Tubulin Inhibiting Agent [EPC]

Package NDCNDC-11Package
62135-494-0162135049401100 TABLET in 1 BOTTLE, PLASTIC (62135-494-01)
62135-494-306213504943030 TABLET in 1 BOTTLE, PLASTIC (62135-494-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/efb8a660-802c-4ca6-bbff-ad7b48b91aef
  • NADAC price for package 62135049401

    GET /v1/drugs/nadac/62135049401
  • NADAC price for package 62135049430

    GET /v1/drugs/nadac/62135049430

Use it

Look up 62135-494 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62135-494 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62135-494. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.